The companies that reported earnings before the markets open on Thursday are: AT&T, Procter & Gamble, Caterpillar, Altria, Bristol-Myers Squibb, Eli Lilly, Motorola Solutions, Colgate-Palmolive, Celgene and Lockheed Martin.

* AT&T (NYSE:T) said fourth quarter earnings, excluding a charge of 26 cents from a pension accounting change, rose 10 percent to 55 cents a share. Earnings attributable to AT&T fell to $1.1 billion or 18 cents a share from $2.7 billion or 46 cents a share last year. Total operating revenue rose 2 percent to $31.36 billion. Analysts, on average, polled by Thomson Reuters expected earnings of 54 cents per share, on revenue of $31.5 billion. Postpaid churn was 1.15 percent, while total churn was 1.32 percent versus 1.42 percent in the fourth quarter of 2009, it said. In 2011, AT&T expects consolidated revenue growth along with an expansion in consolidated, wireline and wireless operating margins. Achieving these targets will lead to expected mid-single digit or better earnings per share growth versus 2010 earnings, excluding changes in capitalized interest, it said. The stock ended Wednesday's regular trading at $28.73.

* Procter & Gamble Co. (NYSE: PG) said second quarter core earnings per share rose 3 percent to $1.13, helped by organic sales growth adding that it is on track to deliver seven to nine percent growth for the year. Net sales increased two percent to $21.35 billion and organic sales grew three percent for the quarter. Analysts expected PG to earn $1.10 per share on revenue of $21.58 billion. Net earnings fell 28 percent to $3.33 billion and earnings per share declined 26 percent to $1.11, due to the gain on the sale of the global pharmaceuticals business in the prior year period, it said. For the third quarter, the company forecasts core earnings per share in the range of $0.95 to $1.00, while analysts expect $0.99. Net sales growth is estimated to be five to seven percent for the third quarter. The company maintained its guidance for core earnings of $3.91 to $4.01 per share for the full year. The stock closed Wednesday's regular trading at $66.11.

* Caterpillar Inc. (NYSE: CAT) said fourth quarter profit quadrupled as sales soared 62 percent driven by substantial increase in product demand, and it guided 2011 earnings above analysts expectations. Profit was $968 million or $1.47 per share from $232 million or $0.36 a share in the year-ago quarter. Sales and revenue rose to $12.8 billion from $7.9 billion. Analysts expected CAT to report profit of $1.27 a share on revenue of $11.63 billion. For 2011, the company expects profit to be near $6.00 per share and sales and revenue to exceed $50 billion. Analysts expect profit of $5.85 per share on revenue of $49.77 billion. The stock ended Wednesday's regular trading at $95.75.

* Altria Group (NYSE: MO) reported a 13 percent rise in fourth quarter adjusted earnings per share to 44 cents, in line with analysts expectations. The company said reported earnings per share grew 25.7 percent to $0.44 mainly due to higher operating companies income from cigarettes and smokeless products. Net revenue fell 1.4 percent to $5.93 billion. Lookin ahead for 2011, Altria said the business environment is likely to remain challenging, as adult consumers remain under economic pressure and face high unemployment. Altria forecasts 2011 adjusted earnings per share to be in the range of $2.01 to $2.07, representing a growth rate of 6 percent to 9 percent in 2010. Shares of MO ended Wednesday's regular trading at $24.26.

* Eli Lilly (NYSE: LLY) posted a better-than-expected quarterly profit, as higher volume drove four percent revenue growth. For the fourth quarter, the company reported non-GAAP earnings of $1.23 billion or $1.11 per share, up from $999.4 million or $0.91 cents a share a year earlier. Revenue rose to $6.19 billion from $5.9 billion. Analysts expected profit of $1.10 per share on revenue of $5.99 billion. Sales of Cymbalta rose 19 percent, while Gemzar sales fell 22 percent due to the impact of generic competition which began November 15, it said. The company expects full-year 2011 earnings per share to be in the range of $4.15 to $4.30 on a non-GAAP basis, while analysts expect $4.32 a share. Shares of LLY closed Wednesday's regular trading at $34.95.

* Bristol-Myers Squibb Co. (NYSE: BMY) reported fourth quarter non-GAAP net earnings from continuing operations of $807 million or $0.47 per share, compared with $928 million or $0.47 per share for the same period in 2009. Net sales rose 2 percent to $5.1 billion. Analysts expected profit of $0.47 per share on revenue of $5.05 billion. Gross margin was 72.3 percent in the fourth quarter, compared with 71.5 percent last year. Net earnings per share fell to $0.28 from $4.06 in the year-ago quarter, which includes a $7.2 billion after tax gain or $3.62 per share, attributed to the split-off of Mead Johnson Nutrition Co, it said. Global sales of Avapro/Avalide fell 26 percent, while sales of Sprycel rose 42 percent. Bristol-Myers Squibb set its 2011 non-GAAP earnings per share forecast range from $2.10 to $2.20, while analysts expect $2.25 per share. Shares of BMY ended Wednesday's regular trading at $25.93.

* Motorola Solutions Inc. (NYSE: MSI), formerly Motorola, Inc., posted fourth quarter earnings from continuing operations of $220 million or 61 cents a share, compared with $50 million or 15 cents a share a year earlier. Net sales rose to $5.66 billion from $4.79 billion. Pro forma non-GAAP operating earnings were of $352 million, compared with $351 million in fourth-quarter 2009. For the first quarter, MSI sees sales growth of 3-4 percent over the first quarter of 2010 and earnings per share from continuing operations of $0.29 to $0.34 per share. Shares of MSI closed Wednesday's regular trading at $39.24.

* Lockheed Martin Corp. (NYSE: LMT) said earnings from continuing operations for the fourth quarter were $829 million, or $2.30 per share, compared with $836 million, or $2.19 per diluted share in the year-ago quarter. Net sales rose to $12.8 billion from $12.2 billion. Analysts expected profit of $2.10 per share on revenue of $12.5 billion. For 2011, LMT expects earnings from continuing operations in the range of $6.70 to $7.00 on sales of between $45.75 billion and $47.25 billion. Analysts expect earnings of $6.67 per share for 2011 on sales of $46.33 billion. The stock ended Wednesday's regular trading at $78.39.

* Celgene Corp. (NASDAQ: CELG) reported higher quarterly profit, as revenue rose 38 percent, driven by growth in global sales of Revlimid and Vidaza cancer drugs. Non-GAAP earnings increased to $347.6 million or 73 cents a share from $290.3 million or 62 cents a share in the year-ago quarter. GAAP profit fell to $213.6 million or 45 cents a share from $254.2 million or 54 cents a share. Non-GAAP total revenue was $1.048 billion, an increase of 38 percent from 2009, it said. Analysts expected CELG to earn 73 cents a share on revenue of $1.04 billion. Shares of Celgene closed Wednesday's regular trading at $56.19.

Nyse Unemployment Cancer Unemployment